Xbrane Biopharma AB (XBRANE) — Free Cash Flow Generation Index

Latest as of December 2024: 0.82x

Xbrane Biopharma AB (XBRANE) has a Free Cash Flow Generation Index of 0.82x as of December 2024. Free cash flow of Skr76.61 Million represents 1% of operating cash flow (Skr93.91 Million). Read Xbrane Biopharma AB balance sheet liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.82x
Free Cash Flow / Operating CF

Free Cash Flow

Skr76.61 Million
SEK

Operating Cash Flow

Skr93.91 Million
SEK

Capital Expenditures

Skr17.30 Million
SEK

Xbrane Biopharma AB Free Cash Flow Generation Index (2018–2018)

Historical FCF Generation Index trend for Xbrane Biopharma AB across 1 annual periods. Explore XBRANE capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Xbrane Biopharma AB (2018–2018)

Year-by-year Free Cash Flow Generation Index for Xbrane Biopharma AB. For the full company profile including market capitalisation, see XBRANE market cap overview.

Year FCG Index Free Cash Flow (SEK) Operating CF Capital Expenditures YoY Change
2018 0.97x Skr45.11 Million Skr46.71 Million Skr1.60 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).